Johnson & Johnson's quest to develop effective IBD treatments
Inflammatory bowel disease doesn't have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.| JNJ.com
